Th9-arterial endothelial cell crosstalk promotes psoriatic atherosclerosis
These findings suggest the Th9<sup>high</sup> state may represent a novel psoriatic ASCVD endotype that could be targeted using precision approaches to prevent ASCVD in at-risk individuals.
Authors
- Alyssa Grogan (ORCID: https://orcid.org/0000-0002-1505-3311)
- José Pérez (ORCID: https://orcid.org/0000-0002-8311-522X)
- Joshua D. Milner (ORCID: https://orcid.org/0000-0002-3913-3869)
- Aarohan M Burma
- Guido H. Falduto (ORCID: https://orcid.org/0000-0002-6871-0397)
- Justin Rodante (ORCID: https://orcid.org/0000-0002-2435-7747)
- Yvonne Baumer (ORCID: https://orcid.org/0000-0001-7400-0773)
- Nehal N. Mehta (ORCID: https://orcid.org/0000-0003-4939-5130)
- Daniella M. Schwartz (ORCID: https://orcid.org/0000-0002-1660-8438)
- Ishita Baral (ORCID: https://orcid.org/0000-0003-4702-1274)
- Pamela A. Frischmeyer‐Guerrerio (ORCID: https://orcid.org/0000-0003-2259-5546)
- Tatsuya Shiraki (ORCID: https://orcid.org/0000-0003-1901-1642)
- Aloke V. Finn (ORCID: https://orcid.org/0000-0003-0359-0184)
- Tiffany M. Powell‐Wiley (ORCID: https://orcid.org/0000-0001-9488-4131)
- McKella Sylvester
- Aran Son (ORCID: https://orcid.org/0000-0003-4487-7026)
- Kyoungin Cho
- Moses M. Kitakule
- Marcus Y. Chen (ORCID: https://orcid.org/0000-0003-0743-9369)
- Amit K. Dey (ORCID: https://orcid.org/0000-0002-7750-910X)
- Liang Guo (ORCID: https://orcid.org/0000-0002-8748-5770)
- Cristhian A. Gutierrez-Huerta
- Kyle M. Jones
- Bhavani Taramangalam
- Jaspal S Khillan
Institutions
- University of Maryland, Baltimore (US)
- Roswell Park Comprehensive Cancer Center (US)
- National Institutes of Health (US)
- Scuola Internazionale Superiore di Studi Avanzati (IT)
- University of Pittsburgh (US)
- Virginia Commonwealth University (US)
- George Washington University (US)
- Medical College of Wisconsin (US)
- Columbia University Irving Medical Center (US)
- Alabama College of Osteopathic Medicine (US)
- Mount Sinai Hospital (US)
- National Heart, Lung, and Blood Institute (US)
- National Institute of Allergy and Infectious Diseases (US)
- CVPath Institute (US)
- AstraZeneca (Poland) (PL)
- AstraZeneca (Finland) (FI)
- National Institute on Minority Health and Health Disparities (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Annals of the Rheumatic Diseases
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.ard.2025.11.008
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Heart, Lung, and Blood Institute